Literature DB >> 22139958

Phenotype-genotype correlations in congenital isolated growth hormone deficiency (IGHD).

Kyriaki S Alatzoglou1, Mehul T Dattani.   

Abstract

Isolated growth hormone deficiency (IGHD) may be congenital, often due to genetic mutations, or acquired as a result of other factors such as cranial irradiation. The commonest genes implicated in its genetic etiology are those encoding growth hormone (GH1) and the receptor for GH-releasing hormone (GHRHR). Rarely, IGHD may be caused by mutations in transcription factors (HESX1, SOX3, OTX2) or be the first presentation before the development of other pituitary hormone deficiencies. IGHD has been classified in four genetic forms (type IA, IB, II and III). Despite the increasing number of genes implicated in the etiology of IGHD, mutations in known genes account only for a small percentage of cases; therefore, other as yet unidentified factors may be implicated in its etiology. Although there is no strict genotype/phenotype correlation in patients with IGHD, there are some emerging patterns that may guide us towards a genetic diagnosis of the condition. There is increasing understanding that the phenotype of patients with IGHD is highly variable and sometimes even evolving, dictating the need for long term follow-up in these cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139958     DOI: 10.1007/s12098-011-0614-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  57 in total

1.  Expanding the spectrum of mutations in GH1 and GHRHR: genetic screening in a large cohort of patients with congenital isolated growth hormone deficiency.

Authors:  Kyriaki S Alatzoglou; James P Turton; Daniel Kelberman; Peter E Clayton; Ameeta Mehta; Charles Buchanan; Simon Aylwin; Elisabeth C Crowne; Henrik T Christesen; Niels T Hertel; Peter J Trainer; Martin O Savage; Jamal Raza; Kausik Banerjee; Sunil K Sinha; Svetlana Ten; Talat Mushtaq; Raja Brauner; Timothy D Cheetham; Peter C Hindmarsh; Primus E Mullis; Mehul T Dattani
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

2.  Three new mutations in the gene for the growth hormone (gh)-releasing hormone receptor in familial isolated gh deficiency type ib.

Authors:  R Salvatori; X Fan; J A Phillips; R Espigares-Martin; I Martin De Lara; K L Freeman; L Plotnick; A Al-Ashwal; M A Levine
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

3.  Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse.

Authors:  M P Wajnrajch; J M Gertner; M D Harbison; S C Chua; R L Leibel
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

4.  Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.

Authors:  P Q Thomas; M T Dattani; J M Brickman; D McNay; G Warne; M Zacharin; F Cameron; J Hurst; K Woods; D Dunger; R Stanhope; S Forrest; I C Robinson; R S Beddington
Journal:  Hum Mol Genet       Date:  2001-01-01       Impact factor: 6.150

5.  Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency.

Authors:  Frédéric Laumonnier; Nathalie Ronce; Ben C J Hamel; Paul Thomas; James Lespinasse; Martine Raynaud; Christine Paringaux; Hans Van Bokhoven; Vera Kalscheuer; Jean-Pierre Fryns; Jamel Chelly; Claude Moraine; Sylvain Briault
Journal:  Am J Hum Genet       Date:  2002-11-08       Impact factor: 11.025

6.  Prevalence of human GH-1 gene alterations in patients with isolated growth hormone deficiency.

Authors:  J K Wagner; A Eblé; P C Hindmarsh; P E Mullis
Journal:  Pediatr Res       Date:  1998-01       Impact factor: 3.756

7.  A molecular basis for variation in clinical severity of isolated growth hormone deficiency type II.

Authors:  Rizwan Hamid; John A Phillips; Cindy Holladay; Joy D Cogan; Eric D Austin; Philippe F Backeljauw; Sharon H Travers; James G Patton
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

8.  Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3.

Authors:  N M Solomon; S A Ross; T Morgan; J L Belsky; F A Hol; P S Karnes; N J Hopwood; S E Myers; A S Tan; G L Warne; S M Forrest; P Q Thomas
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

9.  A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency--a clinical research center study.

Authors:  J D Cogan; B Ramel; M Lehto; J Phillips; M Prince; R M Blizzard; T J de Ravel; M Brammert; L Groop
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

10.  Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism.

Authors:  Kathryn S Woods; Maria Cundall; James Turton; Karine Rizotti; Ameeta Mehta; Rodger Palmer; Jacqueline Wong; W K Chong; Mahmoud Al-Zyoud; Maryam El-Ali; Timo Otonkoski; Juan-Pedro Martinez-Barbera; Paul Q Thomas; Iain C Robinson; Robin Lovell-Badge; Karen J Woodward; Mehul T Dattani
Journal:  Am J Hum Genet       Date:  2005-03-30       Impact factor: 11.025

View more
  11 in total

1.  Isolated central hypothyroidism in young siblings as a manifestation of PROP1 deficiency: clinical impact of whole exome sequencing.

Authors:  Ari J Wassner; Laurie E Cohen; Eliana Hechter; Andrew Dauber
Journal:  Horm Res Paediatr       Date:  2013-05-03       Impact factor: 2.852

2.  Molecular genetic studies in isolated growth hormone deficiency (IGHD).

Authors:  Meena P Desai; Shilpa M Mithbawkar; Pradnya S Upadhye; Sudha C Rao; Vijayalakshmi Bhatia; Madhava Vijaykumar
Journal:  Indian J Pediatr       Date:  2013-02-23       Impact factor: 1.967

3.  Deletion of OTX2 in neural ectoderm delays anterior pituitary development.

Authors:  Amanda H Mortensen; Vanessa Schade; Thomas Lamonerie; Sally A Camper
Journal:  Hum Mol Genet       Date:  2014-10-14       Impact factor: 6.150

4.  RNAe: an effective method for targeted protein translation enhancement by artificial non-coding RNA with SINEB2 repeat.

Authors:  Yi Yao; Shouhong Jin; Haizhou Long; Yingting Yu; Zhenming Zhang; Ge Cheng; Chengwei Xu; Yan Ding; Qian Guan; Ning Li; Suneng Fu; Xiang-Jun Chen; Yong-Bin Yan; Hanshuo Zhang; Pei Tong; Yue Tan; Yang Yu; Shushu Fu; Juan Li; Guang-Jun He; Qiong Wu
Journal:  Nucleic Acids Res       Date:  2015-02-26       Impact factor: 16.971

5.  Same Phenotype in Children with Growth Hormone Deficiency and Resistance.

Authors:  Irene Ioimo; Carmen Guarracino; Cristina Meazza; Horacio M Domené; Mauro Bozzola
Journal:  Case Rep Pediatr       Date:  2018-04-15

6.  Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency.

Authors:  Eline Starink; Anita C S Hokken-Koelega; Theo J Visser; Janneke Baan; Robin P Peeters; Laura C G de Graaff
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

7.  The phenotypic spectrum associated with OTX2 mutations in humans.

Authors:  Louise C Gregory; Peter Gergics; Marilena Nakaguma; Hironori Bando; Giuseppa Patti; Mark J McCabe; Qing Fang; Qianyi Ma; Ayse Bilge Ozel; Jun Z Li; Michele Moreira Poina; Alexander A L Jorge; Anna F Figueredo Benedetti; Antonio M Lerario; Ivo J P Arnhold; Berenice B Mendonca; Mohamad Maghnie; Sally A Camper; Luciani R S Carvalho; Mehul T Dattani
Journal:  Eur J Endocrinol       Date:  2021-05-25       Impact factor: 6.558

8.  Polymorphism of the growth hormone gene GH1 in Polish children and adolescents with short stature.

Authors:  Katarzyna Anna Majewska; Andrzej Kedzia; Przemyslaw Kontowicz; Magdalena Prauzinska; Jaroslaw Szydlowski; Marek Switonski; Joanna Nowacka-Woszuk
Journal:  Endocrine       Date:  2020-04-27       Impact factor: 3.633

9.  Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report.

Authors:  Xi Yang; Mingming Yuan; Zhuoguang Li; Yanqin Ying; Ling Hou; Xiaoping Luo
Journal:  BMC Med Genomics       Date:  2021-09-02       Impact factor: 3.063

10.  High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency.

Authors:  Peter Gergics; Cathy Smith; Hironori Bando; Alexander A L Jorge; Denise Rockstroh-Lippold; Sebastian A Vishnopolska; Frederic Castinetti; Mariam Maksutova; Luciani Renata Silveira Carvalho; Julia Hoppmann; Julián Martínez Mayer; Frédérique Albarel; Debora Braslavsky; Ana Keselman; Ignacio Bergadá; Marcelo A Martí; Alexandru Saveanu; Anne Barlier; Rami Abou Jamra; Michael H Guo; Andrew Dauber; Marilena Nakaguma; Berenice B Mendonca; Sajini N Jayakody; A Bilge Ozel; Qing Fang; Qianyi Ma; Jun Z Li; Thierry Brue; María Ines Pérez Millán; Ivo J P Arnhold; Roland Pfaeffle; Jacob O Kitzman; Sally A Camper
Journal:  Am J Hum Genet       Date:  2021-07-15       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.